Ambitious FY27 guidance, but Q1 consolidated PAT negative; execution risk high

Consolidated ₹949.3 Cr up 19.1% YoY; excluding STEAG & foundit impact ~13-14% organic

Consolidated PAT -₹1.6 Cr loss; ₹16 Cr only excluding foundit's -₹14 Cr burn

Consolidated 3.8% matches claim; but NPM at -0.2% shows margin pressure at bottom line

Timing correct; ₹5,200 Cr order book only 11 weeks post-acquisition is strong, but 5-year ramp

Q1 consolidated PAT -₹1.6 Cr; requires ~₹102 Cr in 9 months (only if foundit breaks even & STEAG ramps)

Reflects STEAG integration and strategic reframing toward power/industrial services; no P&L impact, clarifies positioning.

Gap of ₹101.6 Cr in 9 months implies ~₹11.3 Cr/month run-rate from Q2 onwards. Requires STEAG ramp + organic hold + foundit breakeven. Q1 delivery (-₹1.6) does not support.

Management cites Q1 seasonality (telecom soft, food flat QoQ, education vacations) and Q4 sales mobilization to support 15-16% full-year. No formal guidance cut, but near-term outlook hedged.

CEO explicitly stated intent to monetize asset and use proceeds for debt repay. Prior calls promised breakeven; now framed as exit opportunity (implies low confidence on standalone turnaround).

STEAG was in pipeline; German seller exit + entrepreneurial capabilities accelerated deal closure. Thermal O&M in India is 250 GW peak demand, STEAG has 14-16 GW. Renewables growing; total market could double by 2030.

Management team changed ~1 year ago; sales grew ₹15-16 Cr to ₹25 Cr run-rate. Revenue will catch up in P&L in couple of quarters. Will break even by Q4 FY27 and then monetize.

Q1 is seasonally weak (telecom slow, food flat). Sales in Q1 and Q4 mobilizations will drive 15-16% full-year organic growth. Confident mathematically.

STEAG improves plant availability for clients (83-84% → 93-94%). That value is material for power/metal companies. German pedigree + technical expertise gives moat. Renewals built in, risk to solve 5 years out.

Cost base ₹32-33 Cr, will not increase. Sales need to reach ₹38-40 Cr (from ₹25 Cr). FY27 cash burn ₹30-35 Cr. Subscription sales model means revenue catches up later.

STEAG & telecom subcontracting. New base due to acquisition; will stabilize over 2-3 quarters as integration settles.

Targets hold. With STEAG, we may accelerate to FY29 vs FY30. Margins 5.5-6% depending on domestic vs. international mix. Domestic higher (7-8%), international lower.

Q1 had higher ECL due to seasonality (PO renewals). Target 4-4.5% in next couple years. FM at 4% (industry 5%) also has headroom. Food mix (aviation highest, industrial lowest) is lever.

STEAG ~₹1,000 Cr (7-8% ebitda), LSG ~₹110 Cr (high-teen margin), organic 15-16% on ₹3,500 Cr base. Assumes STEAG ramp & telecom capex recovery H2.

Requires significant mix shift (STEAG at 7-8%, LSG at high-teens) and organic margin hold. Q1 organic only 3.8%; need 4%+ to bridge gap.

PAT leverage (+50% YoY) and capital deployment. But depends on ₹100 Cr PAT delivery, which is at risk given Q1 -₹1.6 Cr consolidated result.

STEAG 4 large contracts just went live in Jul-Aug; ramp from ₹76 Cr (11 weeks) to ₹1,000 Cr annualized FY27 assumes no delays, cost overruns, or service failures. Complex integration across FM, security, and engineering teams.

Foundit has missed breakeven commitments multiple times. Q1 shows ₹14 Cr EBITDA loss, flat sales (₹25 Cr), and cost base ₹32-33 Cr. Needs sales to jump to ₹38-40 Cr to breakeven; depends on deferred revenue model (15-18% quarterly conversion).

Q1 organic growth (excl. STEAG) appears ~10-13% vs 15-16% full-year guidance. Telecom saw slowdown, food flat QoQ, security facing margin pressures. Guidance relies on H2 capex recovery and seasonality normalization.

Industrial vertical (STEAG, Hofincons) with large contracts expected to push working capital days from 37 to ~45 days due to longer billing cycles and client approval processes. Funding lag could strain liquidity.

Management guides >₹100 Cr PAT for FY27 (excl. foundit), but Q1 consolidated PAT is -₹1.6 Cr (including foundit loss). Requires ~₹102 Cr in 9 months (~₹11.3 Cr/month run-rate), implying 50%+ margin expansion or significant revenue ramp. High execution risk.